Evidence map›Paper›PMID 29493105›Full record

Trial reportPediatric obesity2018

Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.

R B Jones, T L Alderete, A A Martin, B A Geary, D H Hwang, S L Palmer, M I Goran

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric obesity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 8 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 8 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Review
  11. Review
  12. The role of probiotics in adolescents' obesity.Frontiers in cellular and infection microbiology · 2025
    Review
  13. Article
  14. Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity.Liver international : official journal of the International Association for the Study of the Liver · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R B JonesDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0003-1637-3517
T L AldereteDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
A A MartinDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
B A GearyDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
D H HwangDepartment of Radiology, University of Southern California, Los Angeles, CA, USA.
S L PalmerDepartment of Radiology, University of Southern California, Los Angeles, CA, USA.
M I GoranDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.
University of Southern California · US

Funding

Near-Roadway and Ambient Air Pollution Exposure and the Gut Microbiome: Implications for Obesity and Insulin Resistance in AdolescenceK99ES027853 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALDERETE, TANYA LYNN · 2017 to 2018
$202k
L.K. Whittier Foundation 003457NIEHS NIH HHS K99 ES027853
6 · The paper itself

Abstract

backgroundNumerous studies have shown that there are links between obesity, liver fat and the gut microbiome. However, there are mixed results on whether probiotics could impact the gut microbiome and/or help to decrease liver fat and obesity outcomes.

objectiveThis study aimed to determine whether a probiotic supplement (VSL#3

methodsWe conducted a double-blind, randomized placebo-controlled trial in 19 obese Latino adolescents. The intervention consisted of three packets per day of VSL#3

resultsCompared with placebo, adolescents that received VSL#3 had significant increases in total adiposity (%) (+1.7 ± 0.6 vs. -1.3 ± 0.5, p < 0.01) and trunk adiposity (%) (+3.3 ± 0.8 vs. -1.8 ± 0.8, p < 0.01) with no significant effects on liver fat/fibrosis, insulin/glucose, gut microbial abundances or gut hormones.

conclusionVSL#3 supplementation may lead to increased adiposity in obese Latino adolescents with no significant detectable changes in gut microbiota, gut appetite-regulating hormones, liver fat and fibrosis and dietary intake. However, it is important to note that recruitment efforts were terminated early and the sample size fell short of what was planned for this trial.

Indexed as

AdolescentAnthropometryAppetiteBlood GlucoseBody CompositionChildDouble-Blind MethodFatty LiverFemaleGastrointestinal MicrobiomeHispanic or LatinoHumansInsulinLiver CirrhosisMalePediatric ObesityBlood GlucoseInsulinLiver fatmicrobiomeprobiotictrial

Identifiers

PMID29493105
PMCPMC6113106
OpenAlexW2791651825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.